Work

Interim analysis of a phase II trial of nab-paclitaxel in patients with very advanced relapsed/refractory multiple myeloma (RR-MM).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e19537

Authors: Allison Claire Rosenthal, Rafael Fonseca, Joseph Mikhael, A. Keith Stewart, Angela Mayo, Marta Chesi, Heidi Kosiorek, P. Leif Bergsagel

Institutions: Mayo Clinic in Arizona, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602276296

Cites:

Cited by: 1

Related to: 10